Cardio Diagnostics Holdings Statistics
Cardio Diagnostics Holdings (CDIO) Stock Statistics & Valuation Metrics
Total Valuation
Cardio Diagnostics Holdings has a market cap or net worth of $4.88M. The enterprise value is -$2.44T.
- Market Cap
- $4.88M
- Enterprise Value
- -$2.44T
Share Statistics
Cardio Diagnostics Holdings has 2,959,469 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,959,469
- Owned by Insiders
- 2.72%
- Owned by Institutions
- 3.24%
Financial Efficiency
Cardio Diagnostics Holdings’s return on equity (ROE) is -0.93 and return on invested capital (ROIC) is -84.55%.
- Return on Equity (ROE)
- -0.93
- Return on Assets (ROA)
- -0.84
- Return on Invested Capital (ROIC)
- -84.55%
- Return on Capital Employed (ROCE)
- -0.91
- Revenue Per Employee
- 988.333
- Profits Per Employee
- -433.21K
- Employee Count
- 15
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Cardio Diagnostics Holdings is -0.63. Cardio Diagnostics Holdings’s PEG ratio is -0.11.
- PE Ratio
- -0.63
- PS Ratio
- 311.83
- PB Ratio
- 0.83
- Price to FCF
- -0.82
- Price to Operating Cash Flow
- -0.82
- PEG Ratio
- -0.11
Income Statement
In the last 12 months, Cardio Diagnostics Holdings had revenue of 14.82K and earned -6.50M in profits. Earnings per share was -3.71.
- Revenue
- 14.82K
- Gross Profit
- 14.82K
- Operating Income
- -6.48M
- Pretax Income
- -6.50M
- Net Income
- -6.50M
- EBITDA
- -6.09M
- Earnings Per Share (EPS)
- -3.71
Cash Flow
In the last 12 months, operating cash flow was -5.78M and capital expenditures -18,781, giving a free cash flow of -5.80M billion.
- Operating Cash Flow
- -5.78M
- Free Cash Flow
- -5.80M
- Free Cash Flow per Share
- -1.96
Dividends & Yields
Cardio Diagnostics Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -124.06%
- Earnings Yield
- -138.74%
Stock Price Statistics
- Beta
- 2.17
- 52-Week Price Change
- -35.48%
- 50-Day Moving Average
- 1.83
- 200-Day Moving Average
- 2.08
- Relative Strength Index (RSI)
- 38.90
- Average Volume (3m)
- 27.07K
Financial Position
Cardio Diagnostics Holdings as a current ratio of 9.79, with Debt / Equity ratio of 9.98%
- Current Ratio
- 9.79
- Quick Ratio
- 9.79
- Debt to Market Cap
- 0.06
- Net Debt to EBITDA
- 0.73
- Interest Coverage Ratio
- -438.08
Taxes
In the past 12 months, Cardio Diagnostics Holdings has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Cardio Diagnostics Holdings EV to EBITDA ratio is -0.16, with an EV/FCF ratio of -0.17.
- EV to Sales
- 64.01
- EV to EBITDA
- -0.16
- EV to Free Cash Flow
- -0.17
- EV to Operating Cash Flow
- -0.17
Balance Sheet
Cardio Diagnostics Holdings has $3.94M in cash and marketable securities with $238.88K in debt, giving a net cash position of $3.70M billion.
- Cash & Marketable Securities
- $3.94M
- Total Debt
- $238.88K
- Net Cash
- $3.70M
- Net Cash Per Share
- $1.25
- Tangible Book Value Per Share
- $1.59
Margins
Gross margin is -523.33%, with operating margin of -42649.75%, and net profit margin of -42721.93%.
- Gross Margin
- -523.33%
- Operating Margin
- -42649.75%
- Pretax Margin
- -42721.93%
- Net Profit Margin
- -42721.93%
- EBITDA Margin
- -40775.05%
- EBIT Margin
- -42646.43%
Analyst Forecast
The average price target for Cardio Diagnostics Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -3.78%
- EPS Growth Forecast
- 35.35%

